Historical award
Biomerieux Inc
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (16 days old).
Fiscal year 2026: data through (16 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $11,973.13
- Potential award value
- $11,973.13
- Total obligated to date
- $11,973.13
Source date: Nov 9, 2026
Recorded work
BIOMERIEUX'S NUCLISENS REAGENTS TO BE USED ON THEIR SAMPLE EXTRACTION PLATFORMS THAT HAVE BEEN VALIDATED FOR HIV DRUG RESISTANCE: NUCLISENS EASYMAG, EMAG AND THE MINIMAG WHICH ARE USED BY THE MOLECULAR DIAGNOSTIC AND SURVEILLANCE TEAM'S SURVEILLANCE
Award activity
- Obligations in covered fiscal years
- −$736.45
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75D30124P00045_7523_-NONE-_-NONE-